Introduction: Risk management in asthma and allergic diseases
Late-phase inflammation: Influence on morbidity
Changing concepts of allergic disease: The attempt to keep up with real changes in lifestyles
Clinical comparison of histamine H1–receptor antagonist drugs
Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: Strategies and progress
Chronic urticaria: Pathophysiology and treatment approaches
Risk management in allergen immunotherapy
Legal issues in allergy and clinical immunology